Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00028314 · ClinicalTrials.gov registry record · NA
Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients
A NA study of HIV Infections and Lipodystrophy, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 20
- Study locations
NCT00028314: Completed NA study of HIV Infections and Lipodystrophy, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00028314 is a NA study of HIV Infections and Lipodystrophy that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 150 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (66% lower). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00028314, a NA study of HIV Infections and Lipodystrophy, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goals of this study are to find out if fat wasting and weight loss in the arms and legs of HIV patients taking highly active antiretroviral therapy (HAART) are caused by nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and if wasting can be reversed if the NRTI is stopped and replaced with other anti-HIV drugs.
Conditions Studied
Interventions
- DRUG Nevirapine
- DRUG Lopinavir/Ritonavir
- DRUG Abacavir sulfate
- DRUG Atazanavir/Ritonavir
Study Locations (20)
Illinois
- Northwestern University CRS - Chicago
- Rush Univ. Med. Ctr. ACTG CRS - Chicago
- Cook County Hosp. CORE Ctr. - Chicago
Indiana
- Indiana Univ. School of Medicine, Infectious Disease Research Clinic - Indianapolis
- Indiana Univ. School of Medicine, Wishard Memorial - Indianapolis
- Methodist Hosp. of Indiana - Indianapolis
Ohio
- Univ. of Cincinnati CRS - Cincinnati
- MetroHealth CRS - Cleveland
- The Ohio State University Medical Center - Columbus
California
- UCLA CARE Center CRS - Los Angeles
- Harbor-UCLA Med. Ctr. CRS - Torrance
Massachusetts
- Beth Israel Deaconess Med. Ctr., ACTG CRS - Boston
- SSTAR, Family Healthcare Ctr. - Fall River
Missouri
- St. Louis ConnectCare, Infectious Diseases Clinic - St Louis
- Washington U CRS - St Louis
New York
- Beth Israel Med. Ctr., ACTU - New York
- NY Univ. HIV/AIDS CRS - New York
Colorado
- University of Colorado Hospital CRS - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2002-03 |
| Est. Completion | 2005-03 |
| Phase | NA |
What the finished NCT00028314 record still lists
NCT00028314 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (66% lower).
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 4 interventions - of which Nevirapine is the first listed.
NCT00028314 names 20 study sites across 10 states, led by Illinois, Indiana, Ohio.
Frequently Asked Questions
What is clinical trial NCT00028314 about?
NCT00028314 is a clinical study titled "Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients". The goals of this study are to find out if fat wasting and weight loss in the arms and legs of HIV patients taking highly active antiretroviral therapy (HAART) are caused by nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and if wasting can be reversed if the NRTI is stopped and repla...
What is the current status of trial NCT00028314?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2002-03. Estimated completion is 2005-03.
What conditions does trial NCT00028314 study?
This clinical trial studies the following conditions: HIV Infections, Lipodystrophy, Wasting Disease.
What interventions are being tested in trial NCT00028314?
The interventions under investigation include: Nevirapine (DRUG), Lopinavir/Ritonavir (DRUG), Abacavir sulfate (DRUG), Atazanavir/Ritonavir (DRUG).
Who is sponsoring clinical trial NCT00028314?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00028314 being conducted?
This trial has 20 study locations across California, Colorado, Hawaii, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00028314's enrollment target sits among peer trials
150 212th of 542 higher than 328 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia